Related Experiment Video
Updated: Apr 29, 2026

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
Published on: April 4, 2019
Virologic testing in bronchiolitis: does it change management decisions and predict outcomes?
Fabiola Stollar1, Gabriel Alcoba, Alain Gervaix
1Pediatric Pulmonology Unit, Children's Hospital, University Hospitals of Geneva, Rue Willy-Donzé 6, 1211, Geneva 14, Switzerland, fabipediatria@hotmail.com.
Respiratory syncytial virus (RSV) bronchiolitis presents more severely, but RSV testing offers little help in guiding clinical decisions or predicting patient outcomes like hospitalization or oxygen needs.
Area of Science:
- Pediatrics
- Infectious Diseases
- Respiratory Medicine
Background:
- Bronchiolitis is a common childhood respiratory infection.
- Respiratory syncytial virus (RSV) is a frequent cause of bronchiolitis.
- Differentiating RSV from non-RSV bronchiolitis is crucial for management.
Purpose of the Study:
- To compare clinical, therapeutic, laboratory, and radiological aspects of RSV and non-RSV bronchiolitis.
- To determine if knowing the viral etiology impacts management decisions.
- To assess the predictive value of RSV testing for patient outcomes.
Main Methods:
- Retrospective review of medical charts for children under 1 year old with bronchiolitis.
- Analysis of 221 bronchiolitis episodes over two RSV seasons (2010-2012).
- Comparison of diagnostic tests, clinical severity, and treatment interventions between RSV and non-RSV groups.
Main Results:
- No significant differences in the percentage of diagnostic exams or abnormal lab/radiological findings between RSV and non-RSV groups.
- RSV bronchiolitis cases exhibited a more severe clinical course.
- Virologic testing for RSV showed low specificity for predicting hospitalization, prolonged hospital stays, and need for oxygen or nasogastric tubes.
Conclusions:
- Despite a more severe clinical course in RSV bronchiolitis, virologic testing provides limited value for clinical management decisions.
- The predictive performance of RSV testing for individual patient outcomes is insufficient.
- Further research may be needed to identify better predictors of severity and guide treatment.
More Related Videos
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
09:14An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
Published on: January 26, 2019
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Acute Pyelonephritis II: Diagnostic Studies and Management
Asthma-IV: Nursing Management
First, in...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.